世界のポルフィリン症治療薬市場予測2023-2029:経口式、注射式

【英語タイトル】Porphyrias Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY8585)・商品コード:MMG23LY8585
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:76
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のポルフィリン症治療薬市場規模と予測を収録しています。・世界のポルフィリン症治療薬市場:売上、2018年-2023年、2024年-2029年
・世界のポルフィリン症治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のポルフィリン症治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ポルフィリン症治療薬のグローバル主要企業は、Lundbeck、 Recordati Rare Diseases、 Teva Pharmaceutical、 Apotexなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、ポルフィリン症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のポルフィリン症治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のポルフィリン症治療薬市場:タイプ別市場シェア、2022年
・経口式、注射式

世界のポルフィリン症治療薬市場:用途別、2018年-2023年、2024年-2029年
世界のポルフィリン症治療薬市場:用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界のポルフィリン症治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のポルフィリン症治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるポルフィリン症治療薬のグローバル売上、2018年-2023年
・主要企業におけるポルフィリン症治療薬のグローバル売上シェア、2022年
・主要企業におけるポルフィリン症治療薬のグローバル販売量、2018年-2023年
・主要企業におけるポルフィリン症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Lundbeck、 Recordati Rare Diseases、 Teva Pharmaceutical、 Apotex

*************************************************************

・調査・分析レポートの概要
ポルフィリン症治療薬市場の定義
市場セグメント
世界のポルフィリン症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のポルフィリン症治療薬市場規模
世界のポルフィリン症治療薬市場規模:2022年 VS 2029年
世界のポルフィリン症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのポルフィリン症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のポルフィリン症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:経口式、注射式
ポルフィリン症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院薬局、小売薬局、オンライン薬局
ポルフィリン症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別ポルフィリン症治療薬市場規模 2022年と2029年
地域別ポルフィリン症治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Lundbeck、 Recordati Rare Diseases、 Teva Pharmaceutical、 Apotex
...

Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.
This report aims to provide a comprehensive presentation of the global market for Porphyrias Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porphyrias Drugs. This report contains market size and forecasts of Porphyrias Drugs in global, including the following market information:
Global Porphyrias Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Porphyrias Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Porphyrias Drugs companies in 2022 (%)
The global Porphyrias Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Porphyrias Drugs include Lundbeck, Recordati Rare Diseases, Teva Pharmaceutical and Apotex, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Porphyrias Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Porphyrias Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Injectable
Global Porphyrias Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Porphyrias Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Porphyrias Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Porphyrias Drugs revenues share in global market, 2022 (%)
Key companies Porphyrias Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Porphyrias Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
Outline of Major Chapters:
Chapter 1: Introduces the definition of Porphyrias Drugs, market overview.
Chapter 2: Global Porphyrias Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Porphyrias Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Porphyrias Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Porphyrias Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Porphyrias Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porphyrias Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porphyrias Drugs Overall Market Size
2.1 Global Porphyrias Drugs Market Size: 2022 VS 2029
2.2 Global Porphyrias Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Porphyrias Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Porphyrias Drugs Players in Global Market
3.2 Top Global Porphyrias Drugs Companies Ranked by Revenue
3.3 Global Porphyrias Drugs Revenue by Companies
3.4 Global Porphyrias Drugs Sales by Companies
3.5 Global Porphyrias Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Porphyrias Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Porphyrias Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porphyrias Drugs Players in Global Market
3.8.1 List of Global Tier 1 Porphyrias Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Porphyrias Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Porphyrias Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injectable
4.2 By Type – Global Porphyrias Drugs Revenue & Forecasts
4.2.1 By Type – Global Porphyrias Drugs Revenue, 2018-2023
4.2.2 By Type – Global Porphyrias Drugs Revenue, 2024-2029
4.2.3 By Type – Global Porphyrias Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Porphyrias Drugs Sales & Forecasts
4.3.1 By Type – Global Porphyrias Drugs Sales, 2018-2023
4.3.2 By Type – Global Porphyrias Drugs Sales, 2024-2029
4.3.3 By Type – Global Porphyrias Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Porphyrias Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Porphyrias Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Porphyrias Drugs Revenue & Forecasts
5.2.1 By Application – Global Porphyrias Drugs Revenue, 2018-2023
5.2.2 By Application – Global Porphyrias Drugs Revenue, 2024-2029
5.2.3 By Application – Global Porphyrias Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Porphyrias Drugs Sales & Forecasts
5.3.1 By Application – Global Porphyrias Drugs Sales, 2018-2023
5.3.2 By Application – Global Porphyrias Drugs Sales, 2024-2029
5.3.3 By Application – Global Porphyrias Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Porphyrias Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Porphyrias Drugs Market Size, 2022 & 2029
6.2 By Region – Global Porphyrias Drugs Revenue & Forecasts
6.2.1 By Region – Global Porphyrias Drugs Revenue, 2018-2023
6.2.2 By Region – Global Porphyrias Drugs Revenue, 2024-2029
6.2.3 By Region – Global Porphyrias Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Porphyrias Drugs Sales & Forecasts
6.3.1 By Region – Global Porphyrias Drugs Sales, 2018-2023
6.3.2 By Region – Global Porphyrias Drugs Sales, 2024-2029
6.3.3 By Region – Global Porphyrias Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Porphyrias Drugs Revenue, 2018-2029
6.4.2 By Country – North America Porphyrias Drugs Sales, 2018-2029
6.4.3 US Porphyrias Drugs Market Size, 2018-2029
6.4.4 Canada Porphyrias Drugs Market Size, 2018-2029
6.4.5 Mexico Porphyrias Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Porphyrias Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Porphyrias Drugs Sales, 2018-2029
6.5.3 Germany Porphyrias Drugs Market Size, 2018-2029
6.5.4 France Porphyrias Drugs Market Size, 2018-2029
6.5.5 U.K. Porphyrias Drugs Market Size, 2018-2029
6.5.6 Italy Porphyrias Drugs Market Size, 2018-2029
6.5.7 Russia Porphyrias Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Porphyrias Drugs Market Size, 2018-2029
6.5.9 Benelux Porphyrias Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Porphyrias Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Porphyrias Drugs Sales, 2018-2029
6.6.3 China Porphyrias Drugs Market Size, 2018-2029
6.6.4 Japan Porphyrias Drugs Market Size, 2018-2029
6.6.5 South Korea Porphyrias Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Porphyrias Drugs Market Size, 2018-2029
6.6.7 India Porphyrias Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Porphyrias Drugs Revenue, 2018-2029
6.7.2 By Country – South America Porphyrias Drugs Sales, 2018-2029
6.7.3 Brazil Porphyrias Drugs Market Size, 2018-2029
6.7.4 Argentina Porphyrias Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Porphyrias Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Porphyrias Drugs Sales, 2018-2029
6.8.3 Turkey Porphyrias Drugs Market Size, 2018-2029
6.8.4 Israel Porphyrias Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Porphyrias Drugs Market Size, 2018-2029
6.8.6 UAE Porphyrias Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Lundbeck
7.1.1 Lundbeck Company Summary
7.1.2 Lundbeck Business Overview
7.1.3 Lundbeck Porphyrias Drugs Major Product Offerings
7.1.4 Lundbeck Porphyrias Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Lundbeck Key News & Latest Developments
7.2 Recordati Rare Diseases
7.2.1 Recordati Rare Diseases Company Summary
7.2.2 Recordati Rare Diseases Business Overview
7.2.3 Recordati Rare Diseases Porphyrias Drugs Major Product Offerings
7.2.4 Recordati Rare Diseases Porphyrias Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Recordati Rare Diseases Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Porphyrias Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Porphyrias Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Porphyrias Drugs Major Product Offerings
7.4.4 Apotex Porphyrias Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Apotex Key News & Latest Developments
8 Global Porphyrias Drugs Production Capacity, Analysis
8.1 Global Porphyrias Drugs Production Capacity, 2018-2029
8.2 Porphyrias Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Porphyrias Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porphyrias Drugs Supply Chain Analysis
10.1 Porphyrias Drugs Industry Value Chain
10.2 Porphyrias Drugs Upstream Market
10.3 Porphyrias Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porphyrias Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Porphyrias Drugs in Global Market
Table 2. Top Porphyrias Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Porphyrias Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Porphyrias Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Porphyrias Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Porphyrias Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Porphyrias Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Porphyrias Drugs Product Type
Table 9. List of Global Tier 1 Porphyrias Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porphyrias Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Porphyrias Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Porphyrias Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Porphyrias Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Porphyrias Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Porphyrias Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Porphyrias Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Porphyrias Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Porphyrias Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Porphyrias Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Porphyrias Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Porphyrias Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Porphyrias Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Porphyrias Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Porphyrias Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Porphyrias Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Porphyrias Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Porphyrias Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Porphyrias Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Porphyrias Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Porphyrias Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Porphyrias Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Porphyrias Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Porphyrias Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Porphyrias Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Porphyrias Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Porphyrias Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Porphyrias Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Porphyrias Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Porphyrias Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Porphyrias Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Porphyrias Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Porphyrias Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Porphyrias Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Porphyrias Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Porphyrias Drugs Sales, (K Units), 2024-2029
Table 46. Lundbeck Company Summary
Table 47. Lundbeck Porphyrias Drugs Product Offerings
Table 48. Lundbeck Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Lundbeck Key News & Latest Developments
Table 50. Recordati Rare Diseases Company Summary
Table 51. Recordati Rare Diseases Porphyrias Drugs Product Offerings
Table 52. Recordati Rare Diseases Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Recordati Rare Diseases Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Porphyrias Drugs Product Offerings
Table 56. Teva Pharmaceutical Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Teva Pharmaceutical Key News & Latest Developments
Table 58. Apotex Company Summary
Table 59. Apotex Porphyrias Drugs Product Offerings
Table 60. Apotex Porphyrias Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Apotex Key News & Latest Developments
Table 62. Porphyrias Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Porphyrias Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Porphyrias Drugs Production by Region, 2018-2023 (K Units)
Table 65. Global Porphyrias Drugs Production by Region, 2024-2029 (K Units)
Table 66. Porphyrias Drugs Market Opportunities & Trends in Global Market
Table 67. Porphyrias Drugs Market Drivers in Global Market
Table 68. Porphyrias Drugs Market Restraints in Global Market
Table 69. Porphyrias Drugs Raw Materials
Table 70. Porphyrias Drugs Raw Materials Suppliers in Global Market
Table 71. Typical Porphyrias Drugs Downstream
Table 72. Porphyrias Drugs Downstream Clients in Global Market
Table 73. Porphyrias Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Porphyrias Drugs Segment by Type in 2022
Figure 2. Porphyrias Drugs Segment by Application in 2022
Figure 3. Global Porphyrias Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Porphyrias Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Porphyrias Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Porphyrias Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Porphyrias Drugs Revenue in 2022
Figure 9. By Type - Global Porphyrias Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Porphyrias Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Porphyrias Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Porphyrias Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Porphyrias Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Porphyrias Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Porphyrias Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Porphyrias Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Porphyrias Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Porphyrias Drugs Sales Market Share, 2018-2029
Figure 23. US Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Porphyrias Drugs Sales Market Share, 2018-2029
Figure 28. Germany Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Porphyrias Drugs Sales Market Share, 2018-2029
Figure 37. China Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Porphyrias Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Porphyrias Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Porphyrias Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Porphyrias Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Porphyrias Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Porphyrias Drugs by Region, 2022 VS 2029
Figure 54. Porphyrias Drugs Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のポルフィリン症治療薬市場予測2023-2029:経口式、注射式] (コード:MMG23LY8585)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のポルフィリン症治療薬市場予測2023-2029:経口式、注射式]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆